Modulation of multidrug resistance (MDR) in hematological malignancies-Reference-Cited by-同舟云学术

Modulation of multidrug resistance (MDR) in hematological malignancies

Published:1999 Issue: Volume:10 Page:S53-S60
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Covelli A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/suppl_6/S53/7724412/10-suppl_6-S53.pdf

Reference87 articles.

1. Quantitative model for multiple levels of drug resistance in clinical tumors;Goldie;Cancer Treat Rep,1983

2. Cellular resistance to actmomycin D in Chinese Hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies;Biedler;Cancer Res,1970

3. Amplification of DNA sequences in human multidrug-resistance KB carcinoma cells;Fojo;Proc Natl Acad Sci USA,1985

4. Isolation and expression of a complementary DNA that confers multidrug resistance;Gros;Nature,1986

5. Expression of a multidrug resistance gene in human cancers;Goldstein;J Natl Cancer Inst,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoactivated DNA Nanodrugs Damage Mitochondria to Improve Gene Therapy for Reversing Chemoresistance;ACS Nano;2023-08-22

2. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells;Leukemia Research;2015-04

3. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways;Blood;2008-09-15

4. Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas;APMIS;2008-09

5. Curcumin and cancer: An “old-age” disease with an “age-old” solution;Cancer Letters;2008-08